Engflag

Femotidine

Quick links to important sections

Femotidine

Femotidine_ID

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Femotidine

Quick Facts

Property Description
Active ingredient Famotidine
Form Tablet, Suspension, Injection
Pharmacological class Histamine H₂-receptor antagonist (H₂ blocker)
Common purpose Acid reducer / Suppresses acid production
Origin Synthetic

What is Famotidine and What Type of Medicine is It?

Famotidine is a synthetic, small-molecule medicinal entity classified as a Histamine H₂-receptor antagonist, commonly known as an H₂ blocker. The drug is fundamentally recognized as an effective anti-ulcer agent whose singular active ingredient is the compound Famotidine itself. As a compound in its class with high specificity for the target receptor, the drug targets the stomach's acid-producing cells.

Famotidine is a pure single-ingredient product (monotherapy). This classification distinguishes it from other types of acid reducers, such as antacids or proton pump inhibitors.

Famotidine's Pharmaceutical Forms and Accessibility

Famotidine is supplied in various dosage forms, including conventional oral tablets, chewable tablets, and a liquid oral suspension. The primary route of administration is oral (by mouth), but the medication is also prepared as a sterile solution for intravenous injection to facilitate administration in clinical settings, such as during hospital stays.

The drug is widely accessible, as it is supplied in concentrations for both prescription-only (Rx) use, typically targeting chronic management, and in lower doses available over-the-counter (OTC) for managing occasional, less severe symptoms.

General Purpose: How Famotidine Relates to Stomach Acid

The general purpose of Famotidine is to function as an acid reducer within the gastrointestinal tract. This benefit is achieved by suppressing the production of new gastric fluid. The compound reduces the corrosive potential of stomach fluid by actively suppressing acid production. For instance, this action is typically used to alleviate discomfort experienced during periods of nighttime heartburn. This fundamental mechanism provides relief and supports the natural process of healing for mucosal tissues that may have been aggravated by excessive acid secretion.

Regulatory References

  1. WHO Model Lists of Essential Medicines

What side effects are possible with Femotidine?

Possible Side Effects and Safety Information

The official safety profile for Famotidine, as documented by regulatory agencies such as the FDA and EMA, classifies potential adverse reactions based on frequency and the physiological system affected.

Adverse Reaction Classifications

Adverse reactions are grouped according to standard regulatory frequency categories:

  • Common Reactions (affecting up to 1 in 10 people): Include headache, dizziness, constipation, and diarrhea. These reactions relate primarily to the nervous and gastrointestinal systems.
  • Uncommon Reactions (affecting up to 1 in 100 people): May involve the skin (rash, pruritus), as well as nausea, vomiting, and fatigue.
  • Rare Reactions (affecting up to 1 in 1,000 people): This category includes more serious reactions such as blood dyscrasias (agranulocytosis), psychiatric disturbances (confusion, hallucinations), seizures, and hepatotoxicity (e.g., jaundice).

Serious Adverse Reactions and Safety Constraints

Severe, rare adverse reactions documented in official labeling include Anaphylaxis, severe cutaneous adverse reactions (Stevens-Johnson syndrome), and serious blood and lymphatic system disorders.

Safety notes highlight that the change in gastric pH caused by Famotidine may alter the absorption of other co-administered medications. Furthermore, specific consideration is required for older adults (geriatric) and patients with renal impairment, as these populations have a documented increased risk of Central Nervous System (CNS) effects (e.g., confusion) due to reduced drug clearance. The medication is contraindicated in individuals with known hypersensitivity to famotidine or other H2 receptor antagonists.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes that the clinical manifestations reported in cases of Famotidine overdose are generally similar to the adverse reactions encountered during standard therapeutic use.

Documented Manifestations and Serious Outcomes

Classification Officially Documented Finding
CNS Effects Confusion, delirium, agitation, hallucinations, and seizures are associated with high plasma concentrations.
Systemic Risk The potential for these Central Nervous System (CNS) effects is increased in elderly patients and individuals with moderate to severe renal impairment due to reduced drug clearance.
Management Treatment of overdose is symptomatic and supportive. No specific antidote is known, and measures to remove unabsorbed material, such as activated charcoal, may be employed.

Regulator-Mandated Emergency Actions

If an overdosage is suspected, immediate medical help must be sought right away. Regulatory guidance requires contacting the Poison Control Center for immediate consultation.

Urgent medical services must be called immediately if the person exhibits signs of severe overdose, including collapse, difficulty breathing, seizures, or inability to be awakened. These symptoms signal a need for prompt and potentially life-saving supportive care.

Therapeutic Uses of Femotidine

What Famotidine treats: main uses and benefits

Famotidine is a medication commonly used across domains where additional symptomatic support is needed for conditions presenting with acute or disruptive episodes. Common applications of this medication include addressing key therapeutic areas such as active peptic ulcers (duodenal and gastric), gastroesophageal reflux disease (GERD), and managing pathological hypersecretory conditions.

Famotidine is considered relevant for easing symptoms related to inflammatory or irritative states, such as heartburn, stomach pain, and difficulty swallowing. It provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during symptomatic periods.

The drug is relevant in contexts involving heightened systemic burden, including treatment for active ulcers, symptomatic non-erosive GERD, and erosive esophagitis. The symptomatic assistance it provides may help maintain a sense of stability when symptoms are more noticeable.

“This medication assists with maintaining functional stability in contexts involving heightened systemic burden.”

Quick Fact: Relief for Symptoms related to physical discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Famotidine?

Famotidine eligibility is strictly governed by regulatory classifications concerning hypersensitivity, age, and physiological function.

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Approved for adults and the elderly under standard labeled conditions. Approved for pediatric patients 40 kg and above (tablets) and those 1 year of age and older (other forms).
Populations for whom use is contraindicated Patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to Famotidine or to any other H₂-receptor antagonist.
Condition-specific eligibility rules Patients with moderate to severe renal impairment require a mandatory dosage adjustment due to reduced clearance. Patients with suspected gastric malignancy must have the condition excluded prior to treatment for gastric ulcers.
Pregnancy and lactation eligibility status Pregnancy: Safe use is not established; use only if clearly needed. Lactation/Breastfeeding: Famotidine is excreted in human breast milk; consideration should be given to stopping the drug or nursing.

Eligibility Classifications (High-Level)

Official regulatory documents define eligibility through explicit, mandatory restrictions, most notably the absolute contraindication based on hypersensitivity history. Conditional use applies to populations with impaired renal function or during pregnancy/lactation, where use is only permitted under specific, labeled circumstances. Age-related eligibility is established across the lifespan, but is conditional on the patient's weight and the specific formulation used.

What should I know about interactions with other medicines?

The regulatory interaction profile for Famotidine is structured around interactions that alter the systemic exposure of co-administered medicines. These interactions are classified based on the mechanism of altered pharmacokinetics.

Classification Official Interaction Statement
Exposure Reduction (Gastric pH) The reduction of stomach acid significantly decreases the absorption of medicines requiring an acidic environment for solubility, leading to a documented loss of efficacy. This pattern applies to specific antifungals (e.g., Ketoconazole) and certain HIV antivirals and tyrosine kinase inhibitors.
Increased Drug Exposure (Metabolic & Renal) Co-administration with Tizanidine, a CYP1A2 substrate, may result in a substantial increase in Tizanidine blood concentrations. Furthermore, Probenecid is documented to inhibit the renal tubular secretion of Famotidine, thereby increasing Famotidine's own plasma concentrations by approximately 50%. Concomitant use with both Tizanidine and Probenecid is generally restricted or recommended to be avoided.
Timing Constraints To prevent reduced Famotidine absorption, the administration of Antacids and Sucralfate must be formally separated. Regulatory labels specify that these substances should not be taken within 1 to 2 hours of a Famotidine dose.
Population-Specific Notes For patients with renal impairment (creatinine clearance less than 30 mL/min), the reduced clearance of Famotidine leads to a prolonged presence in the bloodstream, resulting in higher systemic exposure and an associated risk of CNS reactions.

Mechanism of Action

Famotidine acts through a mechanism that results in diminished hydrochloric acid secretion by the parietal cells of the stomach. Its action centers on interrupting a specific signaling pathway that regulates acid output.

Blockade of Histamine H2 Receptors on Parietal Cells

This mechanism is initiated by Famotidine acting as a competitive antagonist that binds directly and reversibly to the histamine H2 receptors found on the basolateral membrane of the acid-secreting parietal cells. By occupying these receptors, Famotidine prevents the natural signaling molecule, histamine, from binding and activating the cell. This targeted blockade modulates a key pathway involved in the regulation of hydrochloric acid production.

Modulation of the Acid Secretion Cascade

The drug's primary action diminishes the intracellular signaling cascade normally initiated by H2 receptor activation. This interference reduces the subsequent increase in downstream second messengers, specifically cyclic adenosine monophosphate ( cAMP), which are necessary to stimulate the final H^+/ K^+-ATPase (acid pump). By suppressing this secretory signal, Famotidine reduces the cellular effect of histamine mediator activity. This mechanism culminates in a physiological change: a decrease in the volume and pH (increased pH) of gastric secretions.

Dosage and Administration Information

How to Use Famotidine

Famotidine administration is structured by established protocols that define the approved routes, dose schedules, duration, and necessary adjustments. The medication is typically administered orally via tablets or suspension, but a sterile solution is available for intravenous (IV) use, which is reserved for hospitalized patients who cannot tolerate oral intake.

Official Dosing Regimens

Standard dosing is indication-specific and may be once daily (often at bedtime) or twice daily. For treating an active ulcer, the typical adult regimen is 40 mg once daily or 20 mg twice daily. Therapy for conditions like Erosive Esophagitis may require 20 mg or 40 mg twice daily. The IV form is generally prescribed as 20 mg every 12 hours.

Administration Conditions and Duration

Famotidine may be taken with or without food. For non-prescription (OTC) use, it is taken 10 to 60 minutes prior to eating for symptom prevention. Treatment duration is defined, such as up to 8 weeks for an active ulcer or limited to 14 days for self-treatment. A mandatory dose reduction or extended dosing interval is required for adult patients with moderate to severe renal impairment (creatinine clearance less than 60 mL/min), ensuring the total dose is appropriate for reduced kidney function. If the oral suspension is used, it must be shaken vigorously before measuring the dose.

Recent Clinical Evidence

Research evidence / Overview of Studies for Famotidine

Evidence for Use in Peptic Ulcer Healing and Prevention

The research landscape for the use of Famotidine in peptic ulcer conditions is primarily composed of randomized controlled trials (RCTs). These studies were designed to examine short-term treatment in adult populations with endoscopically confirmed active duodenal and gastric ulcers. Outcomes monitored included the physical healing of the ulcer as seen during follow-up procedures, as well as patient-reported outcomes related to perceived discomfort.

These trials research describes patterns related to the time it took for ulcers to heal over defined time intervals, such as four to eight weeks. Additional research studies explored the long-term patterns after initial healing, specifically monitoring ulcer recurrence rates to understand the long-term patterns of recurrence. Evidence is limited when considering the need for continuous, long-term use of Famotidine for an active ulcer beyond the period needed for initial healing.

Evidence for Use in Managing Reflux and Esophagitis

For conditions like Gastroesophageal Reflux Disease (GERD) and erosive esophagitis, evidence was evaluated in controlled trials and systematic reviews. These studies research examined patient groups, including adults diagnosed with both tissue injury (erosive esophagitis) and those experiencing symptoms without visible damage (non-erosive GERD).

The research data show patterns related to the healing of tissue damage in patients with erosive esophagitis at set intervals over intermediate study periods. Physiological studies was evaluated in the medication's impact on acid suppression over a period of time, contributing to the broader evidence landscape. The research documents uncertainty regarding the optimal research strategy for patients whose symptoms are present but who do not have visible tissue damage (non-erosive GERD).

Research Gaps and Remaining Uncertainties

While a substantial body of research exists, certain areas have limitations. Comparative evidence is lacking in some subgroups, and long-term effects are not fully established for the continuous use of the medication in non-active disease management. The research contributes to the understanding of what is known—and what is still uncertain—and the data primarily reflect the specific, controlled conditions under which the studies were conducted.

How should Femotidine be stored and disposed of?

Famotidine Storage and Disposal

Famotidine tablets and the powder for oral suspension must be stored at controlled room temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and kept in its original container with the cap tightly closed.

Stability and Handling Constraints

The reconstituted liquid oral suspension has a limited shelf-life and must be discarded after 30 days from the time it is mixed. The liquid suspension must not be allowed to freeze. For household safety, the medication must be stored out of the reach of children at all times.

Official Disposal Rules

Unused or expired Famotidine should primarily be disposed of through a dedicated drug take-back program. If no program is available, the medicine must be mixed with an unappealing substance like dirt or used coffee grounds, sealed in a bag, and then placed in the household trash, following official regulatory guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Femotidine found in:

A-Z Index: